Risk assessment for MHT – When, to whom, which, and how long? (EN)

Watch another essential on-demand webinar titled presented by expert Andres Daste and chaired by Antonio Cano. This informative session provides a comprehensive perspective on Menopausal Hormone Therapy (MHT) risk assessment.

Delve into the critical considerations of when to initiate MHT, whom it benefits most, which type of therapy is appropriate, and how long it should be continued. Gain valuable insights into evidence-based risk assessments and personalized approaches to optimize patient outcomes.

Available in multiple languages, including English, Russian, Spanish, Portuguese, and Mandarin, this webinar is a valuable resource for healthcare professionals seeking to enhance their clinical decision-making in MHT.

Don’t miss this opportunity to learn from leading experts in the field and improve your patient care through informed risk assessments. Watch now and stay at the forefront of evidence-based practices in menopause care. Enhance your clinical insights and patient care by accessing this exclusive content.